Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
198.4 USD | +0.03% | -2.30% | -12.71% |
Apr. 26 | Baird Adjusts Laboratory Corp of America Holdings' Price Target to $244 From $255 | MT |
Apr. 26 | Barclays Adjusts Price Target on Laboratory Corp of America Holdings to $213 From $234 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.71% | 16.72B | |
-14.92% | 84.87B | |
+13.30% | 83.08B | |
+10.92% | 29.4B | |
-3.06% | 16.4B | |
-2.63% | 15.04B | |
-3.97% | 11.88B | |
-1.42% | 11.88B | |
-31.75% | 11.86B | |
+27.44% | 11.64B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- Laboratory of America : Deutsche Bank Adjusts Laboratory Corp of America Holdings PT to $330 From $297 on Q2 Beat & Raised 2021 Guidance, Maintains Buy Rating